Literature DB >> 32202241

Therapies used in rheumatology with relevance to coronavirus disease 2019.

Gilberto Pires da Rosa1, Ester Ferreira2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32202241

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

Review 1.  COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.

Authors:  Dieu-Donné Ouédraogo; Wendlassida Joelle Stéphanie Tiendrébéogo; Fulgence Kaboré; Honoré Ntsiba
Journal:  Clin Rheumatol       Date:  2020-05-29       Impact factor: 2.980

2.  Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs.

Authors:  Soroush Moradi; Maryam Masoumi; Somayeh Mohammadi; Jamshid Vafaeimanesh; Mohaddeseh Mohseni; Hossein Mahdavi; Armin Aryannejad
Journal:  Intern Emerg Med       Date:  2020-10-31       Impact factor: 3.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.